Skip to main content
Clinical Trials/CTRI/2022/01/039662
CTRI/2022/01/039662
Not yet recruiting
Phase 2

A Comparative Phase 2 Clinical Study To Evaluate Efficacy Of Tilakusumadilepa And Vipadikahar Lepa In The Management Of Vipadika With Special Rereference To Palmo-Plantar Psoriasis.

Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik

Eligibility Criteria

Inclusion Criteria

  • Patients with classical signs and symptoms of vipadika \- panipadsphutan,
  • Kharasparshata
  • Patients of Age group \- 18 \- 60 years of Age.
  • Patients willing to participate in the study , who give written consent

Exclusion Criteria

  • Patients below 18 \& above 60 years of age.
  • Patients with other uncontrolled systemic disorders like DM/ HTN/Cardiac disorders/leprosy/Tuberculosis/Malignancy will be excluded.
  • Patients with other skin diseases Like Ringworm, scabies, Eczema etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials